( 189.3 k 24.0 versus 105.6 f 22.1 pmol of mevalonic acid formed/min per mg of protein), while at the same time the remaining enzyme became fully active ('expressed'/'total' ratio = 100%). 'Total' HMG-CoA reductase was reduced to 26% of the control by bromocriptine (49.2 f 1 1.6 pmol of mevalonic acid formed/min per mg of protein) and the 'expressed'/'total' ratio decreased to 75%. The combined anti-hormone agents caused a further slight reduction in 'total' HMG-CoA reductase without affecting the 'expressed'/'total' ratio. Administration of prolactin and growth hormone concurrently with the combined antihormone agents was only able to produce a small reversal of their effects so that the 'total' HMG-CoA reductase activity was still less than one-third of the original controls (60.3 f 17.4 pmol/min per mg of protein) although the ratio of 'expressed' to 'total' remained at the control value of 88%.
Abbreviations used: PRL, prolactin; GH, growth hormone; antirGH, antiserum to rat GH; HMG-CoA reductase, 3-hydroxy-3-methylglutaryl CoA reductase; ACAT, acyl-CoA:cholesterol acyltransferase; CEH, cholesterol ester hydrolase.
ACAT activity was not altered by anti-rGH whether assayed with the cholesterol endogenous to the microsomes (control 5 2.30, respectively) . This increase correlated with enlargement of the cholesterol and cholesterol ester pool in the microsomes, indicating that it was not due to new enzyme molecules, but resulted from the availability of more substrate. Anti-rGH and bromocriptine acted synergistically to give a further increase in ACAT which was doubled in the presence of exogenous cholesterol. Although higher free and esterified cholesterol levels were again observed, this result indicates that new or more active enzyme molecules, as well as increased substrate, were responsible. PRL and GH given concurrently only partially overcame the effects of the antihormone agents.
CEH was not affected by anti-rCH, but bromocriptine caused a 22% increase in the enzyme activity (control 3 15.2 f 14.4, bromocriptine 384 f 2 1.6 pmol of cholesteryl oleate hydrolysed/min per mg of protein). Concurrent administration of the anti-hormone agents showed no synergistic effect on CEH and hormone replacement completely prevented the bromocriptine effects.
The 44"/0 reduction in HMG-CoA reductase which was indicative of a drop in endogenous synthesis of cholesterol correlated with the estimate that 50°/" of the milk yield was dependent on GH in the rat mammary gland [3] . The large difference in activities of ACAT and CEH indicated the existence of different cholesterol and cholesterol ester pools within the mammary gland. The pulsatile nature of the secretion of GH and PRL in relation to the injection regime used in these experiments could explain the differing effects of hormone replacement on the activities of the enzymes studied here. Overall, the results indicate that GH has a major effect on milk synthesis and on cholesterol synthesis within the rat mammary gland.
